Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLVI.b

Pulmonary arterial hypertension

Publications

Amass T, Cumplido J, Aswad B, Whittenhall M, Ventetuolo C, Klinger J

Rapid development of pulmonary hypertension and right ventricular failure due to large vessel intravascular microcrystalline cellulosis in an intravenous drug user.

Pulmonary circulation 2020 Jan-Mar;10;2045894020907871 — 2020 Jan-Mar — 2045894020907871

Lemoine R, Dusmet M

Images in clinical medicine. Pulmonary granulomas in an intravenous drug user.

The New England journal of medicine 2000 Nov 02;343;1312 — 2000 Nov 02 — 1312

Robertson CH, Reynolds RC, Wilson JE

Pulmonary hypertension and foreign body granulomas in intravenous drug abusers. Documentation by cardiac catheterization and lung biopsy.

The American journal of medicine 1976 Nov;61;657-64 — 1976 Nov — 657-64